146 related articles for article (PubMed ID: 31686812)
21. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.
Liu Y; Chen Z; Liu C; Yu D; Lu Z; Zhang N
Biomaterials; 2011 Aug; 32(22):5167-76. PubMed ID: 21521627
[TBL] [Abstract][Full Text] [Related]
22.
Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A
J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616
[No Abstract] [Full Text] [Related]
23. PEG-coated and Gd-loaded fluorescent silica nanoparticles for targeted prostate cancer magnetic resonance imaging and fluorescence imaging.
Jiang W; Fang H; Liu F; Zhou X; Zhao H; He X; Guo D
Int J Nanomedicine; 2019; 14():5611-5622. PubMed ID: 31413566
[No Abstract] [Full Text] [Related]
24. Affibody-Modified Gd@C-Dots with Efficient Renal Clearance for Enhanced MRI of EGFR Expression in Non-Small-Cell Lung Cancer.
Wu Y; Li H; Yan Y; Wang K; Cheng Y; Li Y; Zhu X; Xie J; Sun X
Int J Nanomedicine; 2020; 15():4691-4703. PubMed ID: 32636625
[TBL] [Abstract][Full Text] [Related]
25. Europium-doped gadolinium sulfide nanoparticles as a dual-mode imaging agent for T1-weighted MR and photoluminescence imaging.
Jung J; Kim MA; Cho JH; Lee SJ; Yang I; Cho J; Kim SK; Lee C; Park JK
Biomaterials; 2012 Aug; 33(24):5865-74. PubMed ID: 22617320
[TBL] [Abstract][Full Text] [Related]
26. Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer.
Cui D; Lu X; Yan C; Liu X; Hou M; Xia Q; Xu Y; Liu R
Int J Nanomedicine; 2017; 12():6787-6797. PubMed ID: 28979118
[TBL] [Abstract][Full Text] [Related]
27. Gadolinium-based nanoparticles for highly efficient T1-weighted magnetic resonance imaging.
Lim EK; Kang B; Choi Y; Jang E; Han S; Lee K; Suh JS; Haam S; Huh YM
Nanotechnology; 2014 Jun; 25(24):245103. PubMed ID: 24872113
[TBL] [Abstract][Full Text] [Related]
28. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
29. Iridium(III) and gadolinium(III) loaded and peptide-modified silica nanoparticles for photoluminescence and magnetic resonance (dual) imaging.
Cheng M; Zhou L; Ma J; Mu J; Yi C; Li MJ
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109972. PubMed ID: 31499999
[TBL] [Abstract][Full Text] [Related]
30. Gadolinium oxide nanoparticles and aptamer-functionalized silver nanoclusters-based multimodal molecular imaging nanoprobe for optical/magnetic resonance cancer cell imaging.
Li J; You J; Dai Y; Shi M; Han C; Xu K
Anal Chem; 2014 Nov; 86(22):11306-11. PubMed ID: 25338209
[TBL] [Abstract][Full Text] [Related]
31. Intracellular Construction of Cathepsin B-Guided Gadolinium Nanoparticles for Enhanced T
Wei M; Wang L; Wang Y; Zhang T; Wang C; Wu C; Tian C; Liang G; Yuan Y
Small; 2023 Jul; 19(29):e2300015. PubMed ID: 37029574
[TBL] [Abstract][Full Text] [Related]
32. Gadolinium-Chelated Conjugated Polymer-Based Nanotheranostics for Photoacoustic/Magnetic Resonance/NIR-II Fluorescence Imaging-Guided Cancer Photothermal Therapy.
Hu X; Tang Y; Hu Y; Lu F; Lu X; Wang Y; Li J; Li Y; Ji Y; Wang W; Ye D; Fan Q; Huang W
Theranostics; 2019; 9(14):4168-4181. PubMed ID: 31281539
[TBL] [Abstract][Full Text] [Related]
33. T
Li J; You J; Wu C; Dai Y; Shi M; Dong L; Xu K
Int J Nanomedicine; 2018; 13():4607-4625. PubMed ID: 30127609
[TBL] [Abstract][Full Text] [Related]
34. T1-Weighted MR imaging of liver tumor by gadolinium-encapsulated glycol chitosan nanoparticles without non-specific toxicity in normal tissues.
Na JH; Lee S; Koo H; Han H; Lee KE; Han SJ; Choi SH; Kim H; Lee S; Kwon IC; Choi K; Kim K
Nanoscale; 2016 May; 8(18):9736-45. PubMed ID: 27113247
[TBL] [Abstract][Full Text] [Related]
35. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
Ghaghada KB; Ravoori M; Sabapathy D; Bankson J; Kundra V; Annapragada A
PLoS One; 2009 Oct; 4(10):e7628. PubMed ID: 19893616
[TBL] [Abstract][Full Text] [Related]
36. Improving the MR Imaging Sensitivity of Upconversion Nanoparticles by an Internal and External Incorporation of the Gd(3+) Strategy for in Vivo Tumor-Targeted Imaging.
Du H; Yu J; Guo D; Yang W; Wang J; Zhang B
Langmuir; 2016 Feb; 32(4):1155-65. PubMed ID: 26740341
[TBL] [Abstract][Full Text] [Related]
37. Ultrasound and magnetic resonance imaging of cyclic arginine glycine aspartic acid-gadopentetic acid-polylactic acid in human breast cancer by targeting αvβ3 in xenograft-bearing nude mice.
Fu D; Huang X; Lv Z; Zhang Y; Chen M; Zhang W; Su D
Bioengineered; 2022 Mar; 13(3):7105-7117. PubMed ID: 35259049
[TBL] [Abstract][Full Text] [Related]
38. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.
Zhou Z; Wu X; Kresak A; Griswold M; Lu ZR
Biomaterials; 2013 Oct; 34(31):7683-93. PubMed ID: 23863450
[TBL] [Abstract][Full Text] [Related]
39. Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast cancer through the activation of SRC-family kinases.
Sausgruber N; Coissieux MM; Britschgi A; Wyckoff J; Aceto N; Leroy C; Stadler MB; Voshol H; Bonenfant D; Bentires-Alj M
Oncogene; 2015 Apr; 34(17):2272-8. PubMed ID: 24931162
[TBL] [Abstract][Full Text] [Related]
40. Precise engineering of cetuximab encapsulated gadollium nanoassemblies:
Qi M; Gao S; Nie S; Wang K; Guo L
Drug Deliv; 2021 Dec; 28(1):569-579. PubMed ID: 33709843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
